← All trials
NCT04574999
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 25, 2008
- Primary completion
- Feb 23, 2009
- Completion date
- Feb 23, 2009
- First posted
- Oct 5, 2020
- Last posted
- Dec 11, 2020
- Enrollment
- 167
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- ItalfarmacoLead sponsor
- Hospital Universitario Central de AsturiasOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.